NUNAGEN
NUNAGEN
Engineered Genetic Platforms
NUNAGEN, a King’s College London spinout, utilizes two proprietary 'plug and play' synthetic gene platforms to engineer smart biobased materials that optimize treatment delivery and change future of medicine by producing therapeutics and preventive from within the body.
A biocatalytic gene platform
A molecular assembly gene platform
We are changing the landscape of use of medicines to treat or prevent diseases through creating novel biocatalysts for mRNA and gene therapy.
The genes encoding our biocatalysts are delivered to target cells. The cells express the biocatalysts, which then use cellular metabolites to manufacture drugs within the body for the course of treatment. A single dose treatment or prevention hugely reduces economic costs, cuts thousands tons of CO2 emissions, eliminate problems associated with drug adherence and environmental contamination.
We are innovating construction and delivery of multifunctional therapeutics to address multifaceted diseases such as cancer and viral infections.
The synthetic genes we have created act as a 'plug and play' platform to rapidly create bio-based building blocks that are mixed and matched to construct multifunctional therapeutics targeting a specific disease. The genes can be delivered to assemble a therapeutic from within the body. By reducing manufacturing steps and single dose treatment or prevention we will reduce the costs, cuts tones CO2 emissions, and support patience health.
We’re on a mission to create a healthier, greener world for everyone. Discover how our smart genetic platforms are making a real difference.
BRIGHTER PATIENT OUTCOMES • A CLEANER PLANET • AFFORDABLE CARE FOR ALL •
Brighter futures for patients
NUNAGEN's approach is rooted in science: a single dose that activates your body's own ability to produce therapeutic agents from within. Compared to conventional treatments, our technology is more efficient-achieving faster results with less medications-and less toxic, reducing unwanted side effects. We are transforming medicine into a precise, gentle, and enduring solution for long-term treatment and prevention.
Loving our home planet
At Nunagen, we believe medicine should not come at the expense of the environment. By shifting pharmaceutical production from external manufacturing facilities to the patient’s own body, we significantly reduce industrial emissions and material waste. This approach offers a more sustainable path for healthcare—lowering the ecological footprint of treatment while helping protect the planet for future generations.
Affordable health system
At Nunagen, we believe effective healthcare should be both affordable and widely accessible. By emphasizing prevention and reducing per-treatment costs, our approach helps hospitals and health systems extend care to more people—saving millions of dollars for the healthcare system while lowering out-of-pocket costs for patients. This efficiency-driven model supports equitable access, making quality healthcare a practical reality for all.
Engineering the Future of Medicine
Born from pioneering research in Dr Kourosh Ebrahimi Lab at King's College London, NUNAGEN unites intellectual rigor with industrial agility. Our scientific experts, drawn from the university’s world-leading labs, create bespoke gene platforms designed to surpass current therapeutic limits. We are committed to more than scientific breakthrough; we are constructing a healthcare ecosystem where King’s-led innovation fuels preventive medicine while ensuring sustainability.